The global disposable bronchoscope market size is expected to reach USD 1.69 billion by 2030, growing at a CAGR of 13.9% from 2024 to 2030. Growing incidence rate of chronic respiratory disorders, such as COPD, lung stenosis, lung cancer, tumors, bronchitis, pneumonia, and lung infections are driving market growth. Moreover, the increasing demand for same day surgeries or minimally invasive procedures, which result in shortened hospitalization, quicker recovery, and reduced postoperative care is fostering the growth. The growing awareness levels towards the reduced infection and contamination rate of using disposable bronchoscopes is positively impacting the growth. Frequent product approvals are broadening the product portfolio of key players and catering to the growing need for disposable bronchoscopes.
Several key factors, including the rising incidence of respiratory diseases, the growing prevalence of smoking, and increased product approvals, are significantly contributing to the growth of the market. As the number of respiratory ailments continues to increase, the demand for bronchodilators and related treatments is expected to surge. For instance, as per a 2024 NIH report, acute bronchitis is one of the top 10 most common outpatient illnesses in the U.S., affecting about 5% of adults annually. Consequently, the escalating burden of bronchitis is fueling the demand for effective bronchitis treatment, which in turn, is driving market growth.
The rising prevalence of various respiratory disorders serves as a primary growth driver for the market. The American Cancer Society, Inc. reports that there will be 234,580 new cases of lung cancer and tumors in the U.S., resulting in 125,070 deaths from lung cancer. This rise in lung cancer cases will lead to an increased demand for bronchoscopies to detect and treat lung cancers. Similarly, Cancer Research UK reveals 48,500 new lung cancer cases diagnosed annually. With 58.7% of lung cancer cases occurring in developing countries (as per World Cancer Research Fund International), the global demand for bronchoscopies is anticipated to grow significantly. Furthermore, the potential risks of infection and contamination associated with reusable bronchoscopes create lucrative opportunities for the adoption and expansion of disposable bronchoscope technologies.
This product will be delivered within 2 business days.
Several key factors, including the rising incidence of respiratory diseases, the growing prevalence of smoking, and increased product approvals, are significantly contributing to the growth of the market. As the number of respiratory ailments continues to increase, the demand for bronchodilators and related treatments is expected to surge. For instance, as per a 2024 NIH report, acute bronchitis is one of the top 10 most common outpatient illnesses in the U.S., affecting about 5% of adults annually. Consequently, the escalating burden of bronchitis is fueling the demand for effective bronchitis treatment, which in turn, is driving market growth.
The rising prevalence of various respiratory disorders serves as a primary growth driver for the market. The American Cancer Society, Inc. reports that there will be 234,580 new cases of lung cancer and tumors in the U.S., resulting in 125,070 deaths from lung cancer. This rise in lung cancer cases will lead to an increased demand for bronchoscopies to detect and treat lung cancers. Similarly, Cancer Research UK reveals 48,500 new lung cancer cases diagnosed annually. With 58.7% of lung cancer cases occurring in developing countries (as per World Cancer Research Fund International), the global demand for bronchoscopies is anticipated to grow significantly. Furthermore, the potential risks of infection and contamination associated with reusable bronchoscopes create lucrative opportunities for the adoption and expansion of disposable bronchoscope technologies.
Disposable Bronchoscope Market Report Highlights
- Based on end-use, outpatient facilities dominated with the largest revenue share owing to the growing trend of same-day surgeries. Outpatient facilities, where patients often undergo procedures and are discharged on the same day, have a strong encouragement to adopt disposable bronchoscopes to minimize the risk of infections and maintain high standards of patient safety.
- North America dominated the market with the largest revenue share owing to the advancements in healthcare infrastructure, rapid adoption of technologically advanced solutions, and rising preference for minimally invasive procedures.
- Asia Pacific is estimated to witness the fastest growth during the forecast period. The growth is attributed to improving healthcare infrastructure, substantial economic development, growing geriatric population, and rising prevalence of lung cancers & COPD.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Disposable Bronchoscope Market Variables, Trends & Scope
Chapter 4. Disposable Bronchoscope Market Segment Analysis, By End-use, 2018 -2030 (USD Million)
Chapter 5. Disposable Bronchoscope Market Segment Analysis, By Region and By End-use, 2018-2030 (USD Million)
Chapter 6. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Olympus Corporation
- Ethicon Endo-Surgery, LLC
- Stryker Corporation
- Fujifilm Holdings Corporation
- Boston Scientific Corporation
- Karl Storz GmbH & Co. KG
- Smith & Nephew Inc.
- Richard Wolf GmbH
- Medtronic Plc (Covidien
- PENTAX Medical
- Machida Endoscope Co., Ltd
- Paragon Medical (AMETEK)
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 100 |
| Published | June 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 686.4 Million |
| Forecasted Market Value ( USD | $ 1690 Million |
| Compound Annual Growth Rate | 13.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
